Randolph Guggenheimer III

Equibles does not estimate personal net worth.

Get an email with a short summary when NRX Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get NRXP alerts

About Randolph Guggenheimer III

NRX Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at NRX Pharmaceuticals, Inc. includes Jonathan C. Javitt (CEO, Chairman and Board Member), Jonathan Javitt (CEO and Chairman), Stephen Willard (CEO) and 7 others.

Affiliation history

NRX Pharmaceuticals, Inc. (NRXP)
SEC 8-K

Current
2021-05-21–present

Company network

NRX Pharmaceuticals, Inc.

NRXP

Current role

Biotechnology · Healthcare

Leadership on record at NRX Pharmaceuticals, Inc.

Jonathan C. Javitt CEO, Chairman, Board Member
Jonathan Javitt CEO, Chairman
Stephen Willard CEO
Bennett Kim CFO, Board Member
Dr. Seth Van Voorhees CFO
Ira Strassberg CFO
Michael Abrams CFO
William Fricker CFO
Joseph Casper COO
Joseph M. Casper COO

Recent activity

No call appearances or filed executive changes recorded yet.